Philip Sanger, MD
As an active investor and the founder of multiple ventures, including a publicly traded Medicare-Advantage Health Plan, Dr. Sanger understands what it takes to build a successful healthcare company. After working for more than 25 years as a pulmonary and critical care specialist, he also understands firsthand the complexities and challenges of the healthcare system. He now leverages this knowledge to provide both capital and collaboration as a Managing Partner of TEXO Ventures.
Dr. Sanger has dedicated his career to patients and the entrepreneurial endeavors that would better serve them. In the early 1980s, he served as the Chief of Pulmonary Medicine at the Texas Tech School of Medicine in Lubbock, Texas. By 1990, he had founded and sold a home health durable medical equipment company, launched and grew a profitable Preferred Provider Organization (PPO) to over 50K subscribers, and built a 54K square-foot multi-specialty surgical center, imaging facility, and laboratory that was acquired by a publically traded company. In 1996, he founded Intercede Health and developed it from a 3-person hospitalist company into a leader in comprehensive medical management impacting care for over 1 million patients. He went on to help launch and serve on the Board of HealthSpring through a successful IPO in 2006.
While Dr. Sanger’s vision for hospitalist medicine and medical management strategies can be found in national publications like Managed Healthcare Executive, Health Insurance Underwriters, The Hospitalist Magazine, and Disease Management Advisor, he is most proud of his work with entrepreneurs. Many healthcare startups fail because they don’t understand the regulatory process or they lack the network of industry professionals who will not only validate their product or service, but also drive market traction.
Dr. Sanger currently serves on the Board of Intercede Health, Televero Health and Wenzel Spine. He is also an advisor to Santé Ventures.
Philip Sanger, MD
Naren Singh brings a passion for building digitally enabled healthcare companies to his role as a CEO of Televero Health. Drawing on his experience designing and commercializing products in healthcare and technology industries, he brings a unique understanding of the needs of a healthcare consumer and of the role of technology in creating meaningful consumer experiences.
Prior to joining Televero, Naren was a product marketing professional with a proven track record of finding product-market-fit at early-stage healthcare startups as well as in new venture groups at large enterprises such as Intel and PwC. He is a strategic thinker with a strong ability to analyze market trends, develop data-driven strategies, and roll up his sleeves and execute.
Naren holds a BS in Electrical Engineering from the College of Engineering, Guindy and an MBA from Duke University’s Fuqua School of Business.
Miles is the Customer Success Manager at Televero where he measures and reports client engagement, collaborates on marketing campaigns and thought leadership, and completes market research for competitive analysis, sales, business development and partnership development activities.
Prior to joining Televero, from 2014 to 2016, Miles worked as an Accounting Associate and Data Analyst for Employer Direct Healthcare, LLC. where he audited contracted procedure rates, reviewed network contracts for ancillary terms and conditions, modeled bundled service offerings to provide supporting ROI calculations, and calculated quarterly and annual savings analyses.
Miles graduated with a B.B.A. from Texas Christian University and is currently a member of JDRF, which is a charitable organization dedicated to funding type 1 diabetes research, and The First Tee of Greater Dallas, which is a youth development organization introducing the game of golf and its inherent values to young people.
Vince Friedewald, MD
Dr. Vince Friedewald pursues a multifaceted career founded on his expertise in medicine, writing, and telecommunications. For over 25 years, Dr. Friedewald actively practiced internal medicine and cardiology, initially in 1971 as Director of Diagnostic Laboratories at the Arizona Heart Institute in Phoenix. In 1976 he assumed the position of Chief of Cardiology and Chairman of the Department of Internal Medicine at the Honolulu Medical Group. He returned to Houston in 1982 to practice cardiology and serve as Director of the Cardiac Noninvasive Laboratory and the Cardiac Rehabilitation Program at the KelseySeybold Clinic.
Dr. Friedewald is founder and Chairman of COR Medical Technologies with offices in Austin and Houston. COR’s primary product is a point-of-care decision support system for use on mobile devices, with focus on high risk medical conditions, especially cardiovascular disease, toxins, and infections. Prior to founding COR, Dr. Friedewald was the Founder, Chairman, and Executive Producer of American Medical Communications (AMC) in Houston. In this capacity, he led AMC’s initiative in raising 5 million dollars in venture capital culminating in the company’s acquisition, in January 2000, by Medsite, a New York-based communications company. After selling AMC, Dr. Friedewald was engaged in the development of Argus1 Systems, an Internet-based program for the early detection of biological attack, for use by first responders (police, fire, EMT’s), hospital emergency departments, physician offices, schools, and health departments. Additionally, Dr. Friedewald is the author of 9 books by major publishers, including two textbooks, and has written over 100 scientific articles. He is currently the Clinical Professor of Internal Medicine at the University of Texas Health Sciences Center at Houston.
Vince Friedewald, MD
Pamela Berger is the Chief Financial Officer at Rallyhood Inc where she manages the company’s financial, legal, administrative and operational functions since August of 2016.
From 2011 to 2016, Ms Berger served as CFO for Employer Direct Healthcare Inc , an innovative healthcare service business that provides a high-quality and cost-efficient solution for large self-funded employers and their members. The company was moved to Dallas Texas in 2016.
For over 18 years Ms. Berger has served as Chief Financial Officer for multiple venture-backed start-ups in the technology sector with two successful M&A transactions in that timeframe. Prior to her “start-up” career Ms Berger served as VP of Finance for CCI/Triad and was instrumental in their public debt offering before they were acquired by Epicor. Ms Berger also worked as Controller for EZCORP INC and played a key role in their Initial Public Offering and subsequent public offerings.
Pam is a hands-on, operationally minded leader with an entrepreneurial style and a strong sense of ownership, possessing fiscal integrity, operational excellence and the ability to integrate and work effectively with a multi-disciplinary leadership team, board and external auditors. She is experienced in private equity and venture-backed environments with an appreciation for the smaller company environment, which tends to be fast, nimble and resource-constrained.</p?
Ms Berger has held her CPA license for over 25 years in Texas and holds a B.S in Accounting/Business Administration from Indiana University of Pennsylvania.
Frank has more than 30 years of experience as a performance driven chief executive officer, chief financial officer, hedge fund executive, investment banker, and tax accountant. He is an expert in creating shareholder value, top quartile returns for LP’s, and providing tax advice on complex acquisition and divestiture transactions.
After working his way up to Partner at PricewaterhouseCoopers and becoming the Executive VP and CFO at Luminex Corportion, in 2002, Frank became CEO of Expresiv Technologies, which eventually sold to Softmed Systems Inc., the leading market share provider in electronic back end transcription and medical documentation systems.
Moving to First Q Capital LLC in 2005 as COO, Investment Committee Member, and Partner, Frank served as the firm’s principal external liaison with respect to performance and other communications to both prospective and current investors. He worked in conjunction with the CEO and Portfolio Manager to develop the firm’s marketing strategy and was an integral member in raising the firm’s investment capital.
Frank currently serves as Partner at Reeves Snyder LLP, which assists clients in Healthcare, Technology and Manufacturing verticals by raising multi-million dollar venture and private equity financing rounds and advises clients on licensing, acquisition, and divestiture transactions. Additionally, he is CEO of SPEC Pharma LLC, where he manages joint venture relationships with partners in the development of generic pharmaceuticals.